BioCentury
ARTICLE | Clinical News

Cellmid preclinical data

January 28, 2013 8:00 AM UTC

In a mouse model of diabetic nephropathy, 2 of Cellmid's MK-Abs significantly reduced glomerular sclerosis (<20% vs. 48%, p<0.01) and interstitial volume (12% vs. 35%, p<0.01) vs. untreated controls. ...